Menu
GeneBe

15-40281640-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_001190479.3(ANKRD63):c.947C>T(p.Pro316Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000813 in 1,525,108 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P316R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000066 ( 2 hom., cov: 34)
Exomes 𝑓: 0.000083 ( 3 hom. )

Consequence

ANKRD63
NM_001190479.3 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.89
Variant links:
Genes affected
ANKRD63 (HGNC:40027): (ankyrin repeat domain 63)
PLCB2 (HGNC:9055): (phospholipase C beta 2) The protein encoded by this gene is a phosphodiesterase that catalyzes the hydrolysis of phosphatidylinositol 4,5-bisphosphate to the second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol. The encoded protein is activated by G proteins and has been shown to be involved in the type 2 taste receptor signal transduction pathway. In addition, nuclear factor kappa B can regulate the transcription of this gene, whose protein product is also an important regulator of platelet responses. [provided by RefSeq, Jan 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017280698).
BS2
High Homozygotes in GnomAd at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ANKRD63NM_001190479.3 linkuse as main transcriptc.947C>T p.Pro316Leu missense_variant 1/1 ENST00000434396.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ANKRD63ENST00000434396.2 linkuse as main transcriptc.947C>T p.Pro316Leu missense_variant 1/1 NM_001190479.3 P1
PLCB2ENST00000560009.1 linkuse as main transcriptn.394+2799C>T intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0000657
AC:
10
AN:
152204
Hom.:
2
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000222
AC:
27
AN:
121762
Hom.:
0
AF XY:
0.000284
AC XY:
19
AN XY:
66936
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00120
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000222
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000830
AC:
114
AN:
1372786
Hom.:
3
Cov.:
35
AF XY:
0.000117
AC XY:
79
AN XY:
676356
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00111
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000149
Gnomad4 OTH exome
AF:
0.000140
GnomAD4 genome
AF:
0.0000657
AC:
10
AN:
152322
Hom.:
2
Cov.:
34
AF XY:
0.0000940
AC XY:
7
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.00000756
ExAC
AF:
0.000661
AC:
10

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 08, 2022The c.947C>T (p.P316L) alteration is located in exon 1 (coding exon 1) of the ANKRD63 gene. This alteration results from a C to T substitution at nucleotide position 947, causing the proline (P) at amino acid position 316 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.27
Cadd
Uncertain
25
Dann
Uncertain
1.0
DEOGEN2
Benign
0.0028
T
Eigen
Benign
0.017
Eigen_PC
Benign
0.089
FATHMM_MKL
Benign
0.72
D
LIST_S2
Benign
0.58
T
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.017
T
MetaSVM
Benign
-0.73
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
0.88
D
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-0.39
N
REVEL
Benign
0.15
Sift
Pathogenic
0.0
D
Sift4G
Benign
0.35
T
Vest4
0.25
MutPred
0.17
Gain of catalytic residue at P316 (P = 0.0488);
MVP
0.62
ClinPred
0.095
T
GERP RS
3.7
Varity_R
0.15
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs533726180; hg19: chr15-40573841; API